|
|
Harrow Inc
HROW's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Harrow Inc growth rates, revenue grew
by 30.38 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1184
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -0.28 %
Harrow Inc net loss increased from $-7 millions, to $-14 millions in I. Quarter 2024,
• More on HROW's Growth
|
|
Harrow Inc
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 36.69 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 13.15.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
• More on HROW's Valuation
|
|
|
|
|
Harrow Inc
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 36.69 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 13.15.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
Harrow Inc Price to Book Ratio is at 30.04 lower than Industry Avg. of 84.74. and higher than S&P 500 Avg. of 0
• More on HROW's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
